Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 20 of 1,261
  1. US 12391923

    SIRPα-silenced natural killer (NK) cells

    The Regents of the University of California · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 12391765

    Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

    Takeda Pharmaceutical Company Limited · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  3. US 12390483

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  4. US 12391750

    Anti-C1S antibodies and methods of use thereof

    Bioverativ USA Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  5. US 12389889

    Mouse having a humanized cluster of differentiation 47 gene

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  6. WO 2025168081

    TRAITEMENT D'UN TROUBLE PROLIFÉRATIF DES LYMPHOCYTES B AVEC UN COMPOSÉ ACTIVATEUR DE DÉGRADATION CHIMÉRIQUE

    BEIGENE SUZHOU CO LTD [CN] · Granted Aug 14, 2025 · Expires Aug 9, 2045

    granted
  7. WO 2025168072

    COMPOSÉS HÉTÉROCYCLIQUES, COMPOSITIONS ASSOCIÉES ET MÉTHODES DE TRAITEMENT ASSOCIÉS

    BEIGENE SUZHOU CO LTD [CN] · Granted Aug 14, 2025 · Expires Aug 9, 2045

    granted
  8. WO 2025169901

    CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE PRÉSENTANT UNE ACTIVITÉ D'INDUCTION DE LA DÉCOMPOSITION DE PROTÉINES MUTANTES KRAS

    ASTELLAS PHARMA INC [JP] · Granted Aug 14, 2025 · Expires Aug 9, 2045

    granted
  9. US 12385044

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  10. US 12384790

    Pteridinone compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  11. US 12384776

    Compounds and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  12. US 12383631

    Immune antigen specific IL-18 immunocytokines and uses thereof

    Bright Peak Therapeutics AG · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  13. US 12384770

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  14. US 12383652

    Nanofiber structures and methods of manufacture and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  15. US 12383627

    Antimicrobial scaffolds

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  16. US 12383655

    Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane

    Regents of the University of Minnesota · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  17. US 12383585

    Methods of treatment of infections using bacteria

    Indaptus Therapeutics, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  18. US 12383582

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  19. US 12383587

    AAV triple-plasmid system

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  20. US 12383560

    Compounds and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  21. US 12383540

    Compounds that modulates AMPA receptor function

    University College Cardiff Consultants Limited · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  22. US 12383625

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Serina Therapeutics (AL), Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  23. US 12383545

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  24. US 12383503

    Adagrasib solid pharmaceutical compositions

    Mirati Therapeutics, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.